De Zhou

6PUBLICATIONS
8CO-AUTHORS
Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AcceleratorsHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 01, 2026
Hyperlactataemia in lymphoma-associated haemophagocytic lymphohistiocytosis: Linked to monocytic glycolysis and adverse prognosis.

|Nov 02, 2025
Glofitamab combined with tislelizumab in relapsed/refractory diffuse large B-cell lymphoma: a single-center pilot trial.

De Zhou, Wenjuan Yu, Mixue Xie

|Mar 16, 2025
Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China.

De Zhou, Xianbo Huang, Lixia Zhu

|May 06, 2024
Clinical characteristics of acute myeloid leukaemia patients with a large number of azurophilic granules: A single-centre retrospective study.

Shuqi Zhao, Jinghan Wang, Yinjun Lou

|Feb 15, 2023
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial.

De Zhou, Xianbo Huang, Mixue Xie

|May 14, 2020
Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy.

De Zhou, Ting Shi, Shuqi Zhao

Pageof 1

Frequent Collaborators

4 joint publications

Hongyan Tong

3 joint publications

Wanzhuo Xie

3 joint publications

Jie Jin

2 joint publications

Xiujin Ye